BHCBausch Health Companies Inc.
Is it safe?
Caution warranted: heavy debt (CCC) and big price swings.
Insiders were net sellers (-$259K, 90 days to Oct 8, 2026), selling is often routine.
Highly leveraged, watch solvency. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -87% · now 24% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can BHC take a bad year?
Bausch Health Companies Inc. carries $18.9B of net debt at 9.21× EBITDA: a heavy load to carry through a bad year.
Net debt · as at Q2 2026 · over four years of earnings before interest, tax and depreciation, heavy
- Net debt / EBITDA
- 9.21×
Net debt / EBITDA · 7.05× a year ago · the load is going up
- Interest cover
- 0.55×
Interest cover · operating profit does not cover the interest bill
- Annualised volatility
- 64%
Annualised volatility · three times the market's own swing
Details›
- Total debtQ2 2026
- $20.7B
- Cash and short-term investments
- $1.82B
- Net debt
- $18.9B
- EBITDA, trailing twelve months
- $2.06B
- Operating profit, trailing twelve months
- $883M
- Total debt / EBITDA
- 10.1×
- Annualised volatilitytwo years of daily moves
- 64%
- Worst drawdown on file
- −87%
- Below its 52-week high
- 24%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers, Specialty & Generic
Ranks #13 of 41 by RyuScore